Table 1.
Demographic and clinical characteristics of all participants in the study
| Characteristics | Males (n = 7185) | Females (n = 4833) | F | P |
|---|---|---|---|---|
| Age (years) | 46.0 ± 8.8 | 46.4 ± 9.4 | 5.268 | 0.022 |
| BMI (kg/m2) | 25.6 ± 3.1 | 23.4 ± 3.2 | 1404.995 | <0.001 |
| BFP (%) | 26.1 ± 6.8 | 32.6 ± 6.8 | 2564.495 | <0.001 |
| WHtR | 0.52 ± 0.05 | 0.49 ± 0.06 | 1321.615 | <0.001 |
| WHR | 0.94 ± 0.07 | 0.83 ± 0.07 | 5975.654 | <0.001 |
| SBP (mmHg) | 119 ± 16 | 112 ± 17 | 609.085 | <0.001 |
| DBP (mmHg) | 77 ± 10 | 73 ± 10 | 576.129 | <0.001 |
| LDL-C (mmol/L) | 3.18 ± 0.82 | 3.09 ± 0.84 | 43.198 | <0.001 |
| TC (mmol/L) | 4.97 ± 0.95 | 4.88 ± 0.95 | 25.452 | <0.001 |
| TG (mmol/L) | 1.62 (1.14, 2.44) | 1.06 (0.77, 1.49) | 716.504 | <0.001 |
| HDL-C (mmol/L) | 1.13 ± 0.29 | 1.42 ± 0.35 | 2465.845 | <0.001 |
| FBG (mmol/L) | 5.50 ± 0.93 | 5.17 ± 0.69 | 453.902 | <0.001 |
| 2 h PBG (mmol/L) | 7.05 ± 2.05 | 7.09 ± 1.74 | 0.959 | 0.328 |
| HbA1c (%) | 5.60 ± 0.59 | 5.51 ± 0.49 | 70.189 | <0.001 |
| FINS | 9.56 (6.70, 13.61) | 7.67 (5.51, 10.69) | 378.317 | <0.001 |
| HOMA-IR | 2.30 (1.55, 3.39) | 1.73 (1.21, 2.52) | 403.884 | <0.001 |
| Hs-CRP (mg/L) | 0.14 (0.09, 0.22) | 0.12 (0.08, 0.19) | 37.426 | <0.001 |
| WBC (×109/L) | 6.1 ± 1.5 | 5.4 ± 1.4 | 639.232 | <0.001 |
The data are shown as mean ± SD or median (Q1, Q3). BMI: Body mass index; BFP: Body fat percentage; WHtR: Waist circumference-height ratio; WHR: Waist-hip ratio; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; LDL-C: Low-density lipoprotein-cholesterol; HDL-C: High-density lipoprotein-cholesterol; TC: Total cholesterol; TG: Triglyceride; FBG: Fasting blood glucose; 2 h PBG: 2 h postprandial blood glucose; HbA1c: Glycated hemoglobin; FINS: Fasting insulin; HOMA-IR: Insulin resistance index; hs-CRP: High-sensitivity C-reactive protein; WBC: White blood cell; SD: Standard deviation.